Marex Group plc Ordinary Shares
NASDAQ:MRXFinancial - Capital Markets
+$0.93 today
- Market cap
- $4.61B
- Beta
- -0.00
- P/E (TTM)
- 14.5
- EPS (TTM)
- $4.32
- Dividend yield
- 0.98%
Volume 0.83M
Average 1.11M
MRX Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Marex Group plc Ordinary SharesNASDAQ: MRX
Capital Expenditures · Q2 FY2026 · quarter ended Jun 2026
Capital expenditures turns positive
Q2 FY2026 capital expenditures was $0, compared with -$8.8M a year earlier. Over 3 fiscal years it compounded at +11.7% a year.
Context
- Capital expenditures amounted to 0.4% of revenue in FY2025, down 0.3 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (13.1M) USD
- Year-over-year change
- +34.2%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (13.1M) | +34.2% |
| FY2024 | 2024-12-31 | (19.9M) | -64.5% |
| FY2023 | 2023-12-31 | (12.1M) | -28.7% |
| FY2022 | 2022-12-31 | (9.4M) | -28.8% |
| FY2021 | 2021-12-31 | (7.3M) | — |
Capital Expenditures vs competitors
How MRX compares with its peers on the latest reported figures
- MRX's FY2025 capital expenditures of $13.1M is the smallest of the 10 companies compared; the peer median is $73.2M.
- Its year-over-year change of -34.2% is the 9th highest of 10, against a peer median of +6.4%.
- Capital expenditures amounts to 0.4% of revenue for MRX, versus a peer median of 1.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $2.16B | +6.4% | -18.0% | 1.8% | |
| LTM Sep 2026 | $616M | +120.1% | -2.0% | 0.5% | |
| LTM Sep 2026 | $288M | +21.5% | +20.5% | 3.2% | |
| LTM Aug 2026 | $218.25M | -1.4% | -2.6% | 1.8% | |
| LTM Jun 2026 | $84.15M | +35.5% | -12.3% | 3.8% | |
| LTM Jun 2026 | $73.2M | +18.8% | +9.7% | 0.0% | |
| LTM Jun 2026 | $63.91M | -5.7% | +4.0% | 1.9% | |
| LTM Jun 2026 | $40.34M | -23.7% | -45.9% | 4.6% | |
| LTM Jun 2026 | $30.68M | -50.2% | -9.0% | 0.5% | |
MRXMarex Group plc Ordinary Shares | FY2025 | $13.1M | -34.2% | +11.7% | 0.4% |
| Peer median (excluding MRX) | $73.2M | +6.4% | -2.6% | 1.8% | |
Competitors are the stored peer set for MRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 56.5M | 98.2M | 141.3M | 295.8M | 307.4M |
| Depreciation & Amortization | 10.3M | 13.8M | 21.9M | 28.8M | 36.1M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 1.2M | 16.7M | 20.3M | 29.6M | 43.5M |
| Change in Working Capital | 183.5M | (22M) | 609M | 1.04B | 371.2M |
| Accounts Receivables | (1.57B) | 3.14B | 777.6M | (2.76B) | (2.57B) |
| Inventory | (71.4M) | 44.3M | (127.6M) | 127.6M | (422M) |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 1.82B | (3.21B) | (41M) | 3.67B | 3.36B |
| Other Non-Cash Items | 219.3M | 118.9M | (57.5M) | (231.1M) | (90.7M) |
| Operating Cash Flow | 470.8M | 225.6M | 735M | 1.16B | 667.5M |
| Capital Expenditures | (7.3M) | (9.4M) | (12.1M) | (19.9M) | (13.1M) |
| Acquisitions (Net) | (12.5M) | (36.9M) | (90.3M) | (11M) | (241.6M) |
| Purchases of Investments | 0 | 0 | 0 | (5.1M) | (2.9M) |
| Sales of Investments | 0 | 0 | 6.4M | 700K | 0 |
| Other Investing Activities | 0 | 0 | (4.7M) | (8.2M) | 0 |
| Investing Cash Flow | (19.8M) | (46.3M) | (97.6M) | (35.3M) | (264.3M) |
| Debt Repayment | (7.2M) | 43.4M | (11.4M) | (8.6M) | (24.3M) |
| Common Stock Issued | 0 | 0 | 0 | 73.1M | 0 |
| Common Stock Repurchased | 0 | (7.9M) | (3.1M) | (19.8M) | (44.1M) |
| Dividends Paid | (20M) | (6.6M) | (58.3M) | (77.1M) | (55.5M) |
| Other Financing Activities | 0 | (2.4M) | 0 | 0 | 0 |
| Financing Cash Flow | (27.2M) | 26.5M | (72.8M) | (37.2M) | (123.9M) |
| Effect of Forex Changes | (3.3M) | (7.7M) | 8.8M | (17.9M) | 7.05B |
| Net Change in Cash | 420.5M | 198.1M | 573.4M | 1.07B | 7.33B |
| Free Cash Flow | 463.5M | 216.2M | 722.9M | 1.14B | 654.4M |
Marex Group plc Ordinary Shares
NASDAQ:MRX
Intrinsic Alpha fair value
Locked
Current Price
$64.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.